Get startedLog in
    Picture of Myung In Pharm Co logo

    317450 — Myung In Pharm Co Cashflow Statement

    0.000.00%
    kr flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMid CapNeutral
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual cashflow statement for Myung In Pharm Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

    2022
    December 31st
    2023
    December 31st
    2024
    December 31st
    Period Length:12 M12 M12 M
    Source:PROSPECTUSPROSPECTUSPROSPECTUS
    Standards:
    IFRS
    IFRS
    IFRS
    Status:FinalFinalFinal
    Net Income/Starting Line—74,51268,671
    Depreciation
    Amortisation
    Non-Cash Items—14,33923,435
    Unusual Items
    Purchased R&D
    Other Non-Cash Items
    Changes in Working Capital61,442-24,008-21,303
    Change in Accounts Receivable
    Change in Inventories
    Change in Other Assets
    Change in Accounts Payable
    Change in Accrued Expenses
    Change in Other Liabilities
    Other Operating Cash Flow
    Cash from Operating Activities61,44276,02783,018
    Capital Expenditures-3,403-4,649-10,192
    Purchase of Fixed Assets
    Purchase / Acquisition of Intangibles
    Other Investing Cash Flow Items-85,543-35,161-66,703
    Sale of Fixed Assets
    Sale/Maturity of Investment
    Purchase of Investments
    Cash from Investing Activities-88,946-39,810-76,895
    Financing Cash Flow Items-5,720-18,560-5,600
    Other Financing Cash Flow
    Net Issuance / Retirement of Debt
    Cash from Financing Activities-7,211-20,019-7,675
    Beginning Cash Balance
    Ending Cash Balance
    Net Change in Cash-34,71616,198-1,552